Researchers Get Visa Reprieve; Definium Shares Psychedelics Data — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- International researchers received a court reprieve this week regarding foreign visas, though many are still considering leaving the U.S. for opportunities elsewhere.
- NAFSA executive director Fanta Aw and STAT reporter Jonathan Wosen discussed the visa ruling and what it means for the future of American medical research on the episode.
- Definium's new psychedelics data was also analyzed on the Readout LOUD episode, with the panel examining the findings' significance for the broader psychedelics drug field.
Why it matters: Even with the court reprieve, many international researchers remain undecided about staying in the U.S., leaving the pipeline of American medical research talent uncertain. For the still-immature psychedelics sector, Definium's data release is a watched data point in a field working to demonstrate clinical viability beyond early hype.
Ask SkimNews
